{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:08:40Z","timestamp":1794254920050,"version":"4.9.0"},"reference-count":143,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Vitiligo is an autoimmune disease characterized by the progressive destruction of epidermal melanocytes, leading to skin depigmentation. Although significant advances have been made in understanding the pathogenesis of vitiligo, the intricate interplay between genetic predisposition, environmental factors, oxidative stress, and immune dysregulation remains inadequately understood. In particular, increasing evidence highlights the pivotal role of innate immune activation in initiating and amplifying the adaptive immune response, particularly the activation of autoreactive CD8<jats:sup>+<\/jats:sup> T cells, which are the ultimate effectors of melanocyte destruction. However, current therapeutic approaches offer limited efficacy in modulating this pathway. This review provides a comprehensive analysis of the mechanisms driving innate immune activation in vitiligo, with a particular focus on damage-associated molecular patterns (DAMPs), oxidative stress, and key innate immune cells, including dendritic cells (DCs), natural killer (NK) cells, and innate lymphoid cells (ILCs), and their crucial role in bridging innate and adaptive immunity. We further explore how these factors initiate and sustain an inflammatory cascade that bridges innate stress responses with adaptive immune activation, ultimately exacerbating melanocyte destruction. By synthesizing recent advances, we aim to elucidate the critical role of innate immunity in shaping disease progression and discuss emerging innate immune-targeted therapeutic strategies. Understanding these pathways may open new avenues for more effective and targeted interventions in vitiligo treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1631074","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:42:08Z","timestamp":1760506928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Innate immune activation in vitiligo: mechanisms and pathophysiological implications"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/jamadermatol.2021.1688","article-title":"Vitiligo","volume":"157","author":"LeWitt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04221-8","article-title":"Anatomically distinct fibroblast subsets determine skin autoimmune patterns","volume":"601","author":"Xu","year":"2022","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"adv11643","DOI":"10.2340\/actadv.v103.11643","article-title":"Disease awareness and treatment preferences in vitiligo: A cross-sectional study in China","volume":"103","author":"Zhang","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3892\/etm.2021.9743","article-title":"Novel immunological and genetic factors associated with vitiligo: A review","volume":"21","author":"Said-Fernandez","year":"2021","journal-title":"Exp Ther Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","article-title":"Innate immune activation in neurodegenerative diseases","volume":"57","author":"Castro-Gomez","year":"2024","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.07.018","article-title":"Targeting innate immune pathways for cancer immunotherapy","volume":"56","author":"Cao","year":"2023","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112695","article-title":"Rational design of ros generation nanosystems to regulate innate immunity of macrophages, dendrtical and natural killing cells for immunotherapy","volume":"139","author":"Gao","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of wnt pathway: A promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613056","article-title":"Targeting innate immunity to combat cutaneous stress: the vitiligo perspective","volume":"12","author":"Boniface","year":"2021","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221260","article-title":"Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.jid.2019.03.1148","article-title":"Oxidative stress-induced hmgb1 release from melanocytes: A paracrine mechanism underlying the cutaneous inflammation in vitiligo","volume":"139","author":"Cui","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jid.2021.09.015","article-title":"Vitiligo skin T cells are prone to produce type 1 and type 2 cytokines to induce melanocyte dysfunction and epidermal inflammatory response through jak signaling","volume":"142","author":"Martins","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","article-title":"Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8(+) T cells activation via jak-stat pathway in vitiligo","volume":"139","author":"Chen","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107910","article-title":"The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: A systematic review and meta-analysis","volume":"98","author":"Hu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.jid.2019.03.1165","article-title":"Molecular hydrogen protects human melanocytes from oxidative stress by activating Nrf2 signaling","volume":"140","author":"Fang","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/ijms24054910","article-title":"Vitiligo, from pathogenesis to therapeutic advances: state of the art","volume":"24","author":"Diotallevi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1821780","article-title":"Research progress on targeted antioxidant therapy and vitiligo","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1184079","article-title":"Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers","volume":"13","author":"Lin","year":"2023","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16544","article-title":"The effect of monobenzone cream on oxidative stress and its relationship with serum levels of IL-1beta and IL-18 in vitiligo patients","volume":"23","author":"Khalid-Meften","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.01.082","article-title":"Activation\/deactivation of acetylcholinesterase by H2o2: more evidence for oxidative stress in vitiligo","volume":"315","author":"Schallreuter","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00536","article-title":"Paeoniflorin resists H(2)O(2)-induced oxidative stress in melanocytes by JNK\/Nrf2\/HO-1 pathway","volume":"11","author":"Yuan","year":"2020","journal-title":"Front Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116811","article-title":"Mitoq alleviates H(2)O(2)-induced mitochondrial dysfunction in keratinocytes through the Nrf2\/PINK1 pathway","volume":"234","author":"Zhao","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.08.022","article-title":"TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress","volume":"126","author":"Kang","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2016.10.013","article-title":"Oxidative stress drives CD8(+) T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes","volume":"140","author":"Li","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0133-3","article-title":"The Hsp70 chaperone network","volume":"20","author":"Rosenzweig","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2022.2123864","article-title":"Damage-associated molecular patterns in vitiligo: igniter fuse from oxidative stress to melanocyte loss","volume":"27","author":"Wang","year":"2022","journal-title":"Redox Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15550","article-title":"Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis","volume":"177","author":"Jacquemin","year":"2017","journal-title":"Br J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.08.002","article-title":"The molecular chaperone Hsp70 promotes the proteolytic removal of oxidatively damaged proteins by the proteasome","volume":"99","author":"Reeg","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12183","article-title":"A central role for inducible heat-shock protein 70 in autoimmune vitiligo","volume":"22","author":"Mosenson","year":"2013","journal-title":"Exp Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137365","article-title":"Cyclo(L-pro-L-tyr) isolated from the human skin commensal corynebacterium tuberculostearicum inhibits tyrosinase","volume":"25","author":"Sekino","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biochi.2021.09.007","article-title":"Hinokitiol-induced decreases of tyrosinase and microphthalmia-associated transcription factor are mediated by the endoplasmic reticulum-associated degradation pathway in human melanoma cells","volume":"192","author":"Oyama","year":"2022","journal-title":"Biochimie"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3242","article-title":"Quercetin attenuates the effects of H2o2 on endoplasmic reticulum morphology and tyrosinase export from the endoplasmic reticulum in melanocytes","volume":"11","author":"Guan","year":"2015","journal-title":"Mol Med Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00320-3","article-title":"Pharmacological targeting of endoplasmic reticulum stress in disease","volume":"21","author":"Marciniak","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1550358","article-title":"Cytokines: the yin and yang of vitiligo pathogenesis","volume":"15","author":"Singh","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jid.2024.01.007","article-title":"Membranal expression of calreticulin induced by unfolded protein response in melanocytes: A mechanism underlying oxidative stress-induced autoimmunity in vitiligo","volume":"144","author":"Song","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102664","article-title":"New insight into the role of exosomes in vitiligo","volume":"19","author":"Wong","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6832680","article-title":"Study on the mechanism of mir-125b-5p affecting melanocyte biological behavior and melanogenesis in vitiligo through regulation of mitf","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis Markers"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404064","article-title":"3D-hUMSCs exosomes ameliorate vitiligo by simultaneously potentiating treg cells-mediated immunosuppression and suppressing oxidative stress-induced melanocyte damage","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.11.001","article-title":"An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies","volume":"141","author":"Musumeci","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10565-024-09893-2","article-title":"HMGB1 as an extracellular pro-inflammatory cytokine: implications for drug-induced organic damage","volume":"40","author":"Yuan","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15151","article-title":"Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo","volume":"176","author":"Kim","year":"2017","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.05.035","article-title":"HMGB1\/rage mediates UVB-induced secretory inflammatory response and resistance to apoptosis in human melanocytes","volume":"139","author":"Zhang","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.13032","article-title":"Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo","volume":"35","author":"Wu","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbrc.2021.05.010","article-title":"Baicalein inhibits RLS3-induced ferroptosis in melanocytes","volume":"561","author":"Yang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-023-05716-0","article-title":"The interaction between ferroptosis and inflammatory signaling pathways","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541177","article-title":"Tanshinone IIA inhibits hydrogen peroxide-induced ferroptosis in melanocytes through activating Nrf2 signaling pathway","volume":"110","author":"Li","year":"2024","journal-title":"Pharmacology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1055958","article-title":"Immunometabolism in the pathogenesis of vitiligo","volume":"13","author":"Lyu","year":"2022","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1204a140","article-title":"Serum copper and zinc levels among Iranian vitiligo patients","volume":"12","author":"Khoshdel","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"B58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12964-023-01267-1","article-title":"Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B59","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1460987","article-title":"Recent progress of methods for cuproptosis detection","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"174ra28","DOI":"10.1126\/scitranslmed.3005127","article-title":"Mutant Hsp70 reverses autoimmune depigmentation in vitiligo","volume":"5","author":"Mosenson","year":"2013","journal-title":"Sci Transl Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: an update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.812653","article-title":"Solamargine alleviated UVB-induced inflammation and melanogenesis in human keratinocytes and melanocytes via the P38 MAPK signaling pathway, a promising agent for post-inflammatory hyperpigmentation","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/ced.14374","article-title":"Increased expression of toll-like receptor 7 and 9 in vitiligo melanocytes: A pilot study","volume":"46","author":"Yu","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1810","article-title":"Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies","volume":"14","author":"Sant\u2019Anna-Silva","year":"2024","journal-title":"Clin Transl Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","article-title":"Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo","volume":"61","author":"Wang","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102932","article-title":"Autoimmunity in vitiligo: therapeutic implications and opportunities","volume":"21","author":"Khaitan","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01856-3","article-title":"Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes","volume":"25","author":"Alraies","year":"2024","journal-title":"Nat Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.04.009","article-title":"Vitiligo: advances in pathophysiology research and treatment development","volume":"30","author":"Mukhatayev","year":"2024","journal-title":"Trends Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.646","article-title":"High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma","volume":"78","author":"de Vries","year":"1998","journal-title":"Br J Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.immuni.2022.04.016","article-title":"Dendritic cells can prime anti-tumor CD8(+) T cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0602","article-title":"Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: A phase I trial in metastatic melanoma","volume":"10","author":"Di Nicola","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02168-w","article-title":"Dendritic cells sub-sets are associated with inflammatory cytokine production in progressive vitiligo disease","volume":"313","author":"Srivastava","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41467-019-08337-4","article-title":"Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression","volume":"10","author":"Jin","year":"2019","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.797026","article-title":"Vitiligo: an autoimmune skin disease and its immunomodulatory therapeutic intervention","volume":"9","author":"Chang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41420-024-02150-9","article-title":"Advancements in melanoma immunotherapy: the emergence of extracellular vesicle vaccines","volume":"10","author":"He","year":"2024","journal-title":"Cell Death Discov"},{"key":"B78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jdermsci.2023.04.006","article-title":"Targeting the elevated IFN-gamma in vitiligo patients by human anti- IFN-gamma monoclonal antibody hampers direct cytotoxicity in melanocyte","volume":"110","author":"Ng","year":"2023","journal-title":"J Dermatol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02972","article-title":"JAK inhibition differentially affects NK cell and ILC1 homeostasis","volume":"10","author":"Vian","year":"2019","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071639","article-title":"Current concepts of vitiligo immunopathogenesis","volume":"10","author":"Hlaca","year":"2022","journal-title":"Biomedicines"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1230","article-title":"NKG2D and MICA\/B shedding: A \u2018Tag game\u2019 between nk cells and Malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(86)70085-6","article-title":"Aberrations in T lymphocytes and natural killer cells in vitiligo: A flow cytometric study","volume":"14","author":"Halder","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07301.x","article-title":"Increased expression of the natural killer cell inhibitory receptor CD94\/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis","volume":"155","author":"Liao","year":"2006","journal-title":"Br J Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02681.x","article-title":"Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: A flow cytometric study","volume":"22","author":"Basak","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0190-9622(95)90005-5","article-title":"Natural killer cell and lymphokine-activated killer cell activity against melanocytes in vitiligo","volume":"33","author":"Durham-Pierre","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cytogfr.2023.09.002","article-title":"Unravelling the immunobiology of innate lymphoid cells (ILCS): implications in health and disease","volume":"74","author":"Srivastava","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02337","article-title":"The central nervous system contains ilc1s that differ from nk cells in the response to inflammation","volume":"10","author":"Romero-Suarez","year":"2019","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.07.017","article-title":"In situ mapping of innate lymphoid cells in human skin: evidence for remarkable differences between normal and inflamed skin","volume":"136","author":"Bruggen","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115417","article-title":"Immunosuppression by opioids: mechanisms of action on innate and adaptive immunity","volume":"209","author":"Sun","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149276","article-title":"TTP Protects against Acute Liver Failure by Regulating CCL2 and CCL5 through M6a RNA Methylation","volume":"6","author":"Xiao","year":"2021","journal-title":"JCI Insight"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of cxcr3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5693572","article-title":"Increased serum levels of IFN-gamma, IL-1beta, and il-6 in patients with alopecia areata and nonsegmental vitiligo","volume":"2020","author":"Tomaszewska","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2013.78.021246","article-title":"IL-1beta strikingly enhances antigen-driven CD4 and CD8 T-cell responses","volume":"78","author":"Ben-Sasson","year":"2013","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25259\/IJDVL_793_2023","article-title":"Differential expression of serum CXCL9 and CXCL10 levels in vitiligo patients and their correlation with disease severity and stability: A cross-sectional study","volume":"91","author":"Aulakh","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872458","article-title":"Skin interstitial fluid and plasma multiplex cytokine analysis reveals IFN-gamma signatures and granzyme B as useful biomarker for activity, severity and prognosis assessment in vitiligo","volume":"13","author":"Ng","year":"2022","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: A review","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.07.031","article-title":"Inhibition of the chemokine signal regulator FROUNT by disulfiram ameliorates crescentic glomerulonephritis","volume":"102","author":"Toda","year":"2022","journal-title":"Kidney Int"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417306","article-title":"Vitiligo: pathogenesis and new and emerging treatments","volume":"24","author":"Perez-Bootello","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/path.6247","article-title":"TRPM2-dependent autophagy inhibition exacerbates oxidative stress-induced cxcl16 secretion by keratinocytes in vitiligo","volume":"262","author":"Kang","year":"2024","journal-title":"J Pathol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.12.028","article-title":"Misbalanced CXCL12 and CCL5 chemotactic signals in vitiligo onset and progression","volume":"137","author":"Rezk","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102286","article-title":"CCR5 and inflammatory storm","volume":"96","author":"Lin","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.01.003","article-title":"T cell co-stimulation and functional modulation by innate signals","volume":"41","author":"Imanishi","year":"2020","journal-title":"Trends Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00988","article-title":"The IL-12 cytokine and receptor family in graft-vs.-host disease","volume":"10","author":"Bastian","year":"2019","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156516","article-title":"Macrophage inhibitory factor alters the functionality of macrophages and their involvement in disease pathogenesis of active generalized vitiligo patients","volume":"176","author":"Sain","year":"2024","journal-title":"Cytokine"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c06987","article-title":"Engineered bacterial biomimetic vesicles reprogram tumor-associated macrophages and remodel tumor microenvironment to promote innate and adaptive antitumor immune responses","volume":"18","author":"Zheng","year":"2024","journal-title":"ACS Nano"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.127","article-title":"Rethinking regeneration: empowerment of stem cells by inflammation","volume":"22","author":"Shi","year":"2015","journal-title":"Cell Death Differ"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109574","article-title":"Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo","volume":"114","author":"Deng","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1078\/0171-9335-00423","article-title":"Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo","volume":"83","author":"Steitz","year":"2004","journal-title":"Eur J Cell Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1158883","article-title":"Leptin deficiency in CD8(+) T cells ameliorates non-segmental vitiligo by reducing interferon-gamma and granzyme B","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1117","article-title":"CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis","volume":"7","author":"Wu","year":"2013","journal-title":"Mol Med Rep"},{"key":"B118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2019.01.001","article-title":"Emerging role of immune cell network in autoimmune skin disorders: an update on pemphigus, vitiligo and psoriasis","volume":"45","author":"Das","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12967-024-04965-7","article-title":"An angel or a devil? Current view on the role of CD8(+) T cells in the pathogenesis of myasthenia gravis","volume":"22","author":"Peng","year":"2024","journal-title":"J Transl Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102859","article-title":"Th1-like Treg in vitiligo: an incompetent regulator in immune tolerance","volume":"131","author":"Chen","year":"2022","journal-title":"J Autoimmun"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571959","article-title":"Threonyl-tRNA synthetase promotes T helper type 1 cell responses by inducing dendritic cell maturation and IL-12 production via an NF-kappab pathway","volume":"11","author":"Jung","year":"2020","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600112113","article-title":"NK cells activated by interleukin-4 in cooperation with interleukin-15 exhibit distinctive characteristics","volume":"113","author":"Kiniwa","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-078071","article-title":"B lymphocytes: how they develop and function","volume":"112","author":"LeBien","year":"2008","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00646.x","article-title":"B-lymphocyte contributions to human autoimmune disease","volume":"223","author":"Yanaba","year":"2008","journal-title":"Immunol Rev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2012.03564.x","article-title":"Treanor B. B-cell receptor: from resting state to activate","volume":"136","year":"2012","journal-title":"Immunology"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.226","article-title":"Human memory B cells","volume":"30","author":"Seifert","year":"2016","journal-title":"Leukemia"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00751-7","article-title":"Review of an anti-CD20 monoclonal antibody for the treatment of autoimmune diseases of the skin","volume":"24","author":"Ly","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.10.010","article-title":"Antioxidant supplements in combination with phototherapy for vitiligo: A systematic review and metaanalysis of randomized controlled trials","volume":"85","author":"Jung","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/j.jid.2022.05.1093","article-title":"Addition of narrow-band UVB phototherapy to ruxolitinib cream in patients with vitiligo","volume":"142","author":"Pandya","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S245326","article-title":"Recent progress and future directions: the nano-drug delivery system for the treatment of vitiligo","volume":"15","author":"Sun","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"B137","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jdermsci.2023.12.008","article-title":"JAK inhibitors for the treatment of vitiligo","volume":"113","author":"Inoue","year":"2024","journal-title":"J Dermatol Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19162","article-title":"Topical ruxolitinib: A new treatment for vitiligo","volume":"37","author":"Tavoletti","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.06.007","article-title":"A keratinocyte-tethered biologic enables location-precise treatment in mouse vitiligo","volume":"142","author":"Hsueh","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00403-025-04070-9","article-title":"Efficacy of topical tacrolimus 0.03% ointment in combination with microneedling versus topical phenytoin 2% cream in combination with microneedling for the treatment of non-segmental facial vitiligo","volume":"317","author":"Abdelaziz","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"125106","DOI":"10.1016\/j.ijpharm","article-title":"Recent trends in the treatment of vitiligo using novel drug delivery system","volume":"670","author":"Sahu","year":"2025","journal-title":"Int J Pharm"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084409","article-title":"Pathogenesis of alopecia areata and vitiligo: commonalities and differences","volume":"25","author":"Yamaguchi","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1631074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:42:10Z","timestamp":1760506930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1631074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":143,"alternative-id":["10.3389\/fimmu.2025.1631074"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1631074","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1631074"}}